AARD Stock Summary and Trading Ideas (Aardvark Therapeutics | NASDAQ:AARD)

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

What symbol and exchange does Aardvark Therapeutics shares trade?

Aardvark Therapeutics trades on the NASDAQ stock market under the symbol AARD.

What is Aardvark Therapeutics stock price doing today?

As of December 26, 2025, AARD stock price declined to $13.65 with 75,025 million shares trading.

What is Aardvark Therapeutics's Beta?

AARD has a beta of 1.18, meaning it tends to be more sensitive to market movements. AARD has a correlation of 0.04 to the broad based SPY ETF.

How much is Aardvark Therapeutics worth?

AARD has a market cap of $297.21 million. This is considered a Small Cap stock.

What are the top ETFs holding Aardvark Therapeutics?

The top ETF exchange traded funds that AARD belongs to (by Net Assets): IWM, VTI, IBB, VXF, IWO.

What are the support and resistance levels for Aardvark Therapeutics (AARD)?

AARD support price is $13.23 and resistance is $15.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AARD shares will trade within this expected range on the day.